Course curriculum

  • 1

    Oncology

    • Anal intraepithelial neoplasia and cancer - 3Qs (July 2018)

    • Breast cancer - chemoprophylaxis - 3Qs (July 2019)

    • Breast cancer in men - 3Qs (May 2019)

    • Breast cancer - Genitourinary symptoms - 3Qs (January 2019)

    • Breast cancer survivors - Chronic side effects - 4Qs (July 2018)

    • Breast cancer – triple negative - 4Qs (May 2019)

    • Cell-free DNA testing (May 2019)

    • Cervical adenopathy - 2Qs (March 2020)

    • Cervical cancer screening - 2Qs (September 2018)

    • Classic Hodgkin lymphoma - 5Qs (May 2020)

    • Cutaneous squamous cell carcinoma (March 2019)

    • Esophageal cancer - 5Qs (March 2020)

    • Ewing sarcoma (January 2019)

    • Gallbladder polyps - 2Qs (May 2020)

    • Gestational trophoblastic disease (January 2019)

    • Hepatocellular carcinoma - 2Qs (September 2018)

    • High-grade cervical squamous intraepithelial lesion (July 2018)

    • Inflammatory bowel disease and risk of colon cancer (January 2020)

    • Localized prostate cancer (July 2019)

    • Lung cancer - 4Qs (January 2019)

    • Lung cancer in nonsmokers - 3Qs (September 2019)

    • Lung cancer screening (September 2018)

    • Melanoma - 2Qs (July 2019)

    • Meningioma (March 2020)

    • Microscopic hematuria (July 2018)

    • Oral neoplasms - 2Qs (May 2020)

    • Pancreatic cancer screening (January 2020)

    • Prostate cancer – chemoprevention (May 2019)

    • Seizure and headache in a middle-aged man - 4Qs (November 2019)

    • Unprovoked venous thrombosis - 4Qs (November 2019)

    • Venous thromboembolism and malignancy - 2Qs (January 2019)